Skip to content


You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Wnt signaling in triple negative breast cancer is associated with metastasis

  • Nandini Dey1, 2,
  • Benjamin G Barwick5,
  • Carlos S Moreno4, 5,
  • Maja Ordanic-Kodani10,
  • Zhengjia Chen6,
  • Gabriella Oprea-Ilies13,
  • Weining Tang5,
  • Charles Catzavelos7, 11,
  • Kimberly F Kerstann5,
  • George W SledgeJr.8,
  • Mark Abramovitz9, 12,
  • Mark Bouzyk3,
  • Pradip De1, 2 and
  • Brian R Leyland-Jones1, 2Email author
Contributed equally
BMC Cancer201313:537

Received: 17 April 2013

Accepted: 21 October 2013

Published: 10 November 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
17 Apr 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
3 Sep 2013 Reviewed Reviewer Report - Brian Lehmann
12 Sep 2013 Reviewed Reviewer Report - Caterina Marchiò
16 Oct 2013 Author responded Author comments - Nandini Dey
Resubmission - Version 5
16 Oct 2013 Submitted Manuscript version 5
21 Oct 2013 Editorially accepted
10 Nov 2013 Article published 10.1186/1471-2407-13-537

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Edith Sanford Breast Cancer, Sanford Research
Department of Internal Medicine, University of South Dakota
AKESOgen, Inc.
Department of Pathology and Laboratory Medicine, School of Medicine, Emory University
Winship Cancer Institute
Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University
Department of Pathology, St. Mary’s Hospital, McGill University
Indiana University Cancer Center, Indiana Cancer Pavilion
VM Institute of Research
Centers for Disease Control and Prevention
Director of Pathology, Ville Marie Multidisciplinary Medical Centre
CHU Sainte-Justine Research Centre
Department of Pathology, Emory University School of Medicine